Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad

Descripción del Articulo

Objective: To identify demographic, clinical, laboratory and treatment characteristics associated with mortality in hospitalized patients with SARS-CoV-2 pneumonia in a Level I Hospital of Peruvian Social Security, at La Libertad Network. Materials and Method: Retrospective cohort study. Cox proport...

Descripción completa

Detalles Bibliográficos
Autores: Arana-Calderón, César Alejandro, Chávez-Guevara, Sandra Paola
Formato: artículo
Fecha de Publicación:2022
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/2336
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/2336
Nivel de acceso:acceso abierto
Materia:SARS-CoV-2
COVID-19
Risk Factors
Coronavirus Infections
Hospitalization
Mortality
Survival
Peru
id REVCMP_2446208211f36d8889b393d59e2b0cc8
oai_identifier_str oai:ojs.pkp.sfu.ca:article/2336
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La LibertadFactores de riesgo asociados a mortalidad en pacientes con neumonía por SARS-CoV-2 en un Hospital-I del Seguro Social, Perú-La LibertadArana-Calderón, César AlejandroChávez-Guevara, Sandra PaolaSARS-CoV-2COVID-19Risk FactorsCoronavirus InfectionsHospitalizationMortalitySurvivalPeruObjective: To identify demographic, clinical, laboratory and treatment characteristics associated with mortality in hospitalized patients with SARS-CoV-2 pneumonia in a Level I Hospital of Peruvian Social Security, at La Libertad Network. Materials and Method: Retrospective cohort study. Cox proportional hazards model was used, calculating crude and adjusted hazard ratios (HR), and the Kaplan-Meier estimator was used to evaluate the overall survival curve and for each factor. Results: Of the 158 patients, the diagnosis was confirmed in 79.11%. Nearly 70% (68.99%) were men, the global median age was 65 years (IQR: 52-77), and it was higher in deceased subjects 69 years old (IQR: 61-80 years). Little more than half of this population (53.80%) had comorbidities, such as high blood pressure (27.85%), obesity (22.78%), and diabetes mellitus (13.92%). The median duration of symptoms prior to admission was 9 days (IQR: 6-11 days). HRs were determined for oxygen saturation less than 80% on admission with 0.21 FIO2, leukocytosis with associated lymphopenia, oxygen requirement at 0.80 FIO2 on admission, and moderate-severe ARDS. Such values were 1.54, 1.98, 2.07 and 2.91, respectively. Conclusions: The development of moderate-severe ARDS on admission, leukocytosis associated with lymphopenia, less than 80% hypoxemia on admission at 0.21 FIO2, and high-flow oxygen requirement since admission with 0.80 FIO2, were the only risk factors for mortality.Objetivo: Identificar características demográficas, clínicas, laboratoriales y de tratamiento asociados a la mortalidad en pacientes hospitalizados con neumonía por SARS-CoV-2 en un Hospital I del Seguro Social del Perú de la Red La Libertad. Materiales y Metodo: Estudio de cohorte retrospectiva. Se utilizo el modelo de riesgos proporcionales de Cox calculándose los cocientes de riesgo instantáneos (HR) crudos y ajustados, y el estimador de Kaplan-Meier para evaluar la curva de supervivencia general y con cada factor. Resultados: De los 158 pacientes se confirmó el diagnostico en 79,11%. El 68,99% fueron hombres, la mediana de la edad global fue de 65 años (RIC:52-77), siendo mayor en los fallecidos con 69 años (RIC:61-80 años). El 53,80% tenían comorbilidad, siendo estas la HTA (27,85%), obesidad (22,78%) y diabetes mellitus (13,92%). La mediana de duración de síntomas previo al ingreso fue de 9 días (RIC:6-11 días). Se determinó los HR para la saturación de oxigeno menor de 80% a su ingreso a un FIO2 del 0,21, la leucocitosis con linfopenia asociada, el requerimiento de oxígeno a un FIO2 del 0,80 a su ingreso y el SDRA moderado-severo, los cuales fueron de 1.54, 1.98, 2.07 y 2.91, respectivamente. Conclusiones: El desarrollo de un SDRA moderado-severo a su ingreso, la leucocitosis asociada con linfopenia, la hipoxemia de ingreso menor a 80% a un FIO2 del 0,21, y el requerimiento de oxígeno a alto flujo desde su ingreso con un FIO2 del 0,80, fueron los únicos factores de riesgo de mortalidad encontrados.Colegio Médico del Perú2022-08-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/233610.35663/amp.2022.392.2336ACTA MEDICA PERUANA; Vol 39 No 2 (2022): April - JuneACTA MEDICA PERUANA; Vol. 39 Núm. 2 (2022): Abril - Junio1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2336/1460Copyright (c) 2022 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/23362023-07-06T05:49:26Z
dc.title.none.fl_str_mv Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
Factores de riesgo asociados a mortalidad en pacientes con neumonía por SARS-CoV-2 en un Hospital-I del Seguro Social, Perú-La Libertad
title Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
spellingShingle Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
Arana-Calderón, César Alejandro
SARS-CoV-2
COVID-19
Risk Factors
Coronavirus Infections
Hospitalization
Mortality
Survival
Peru
title_short Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
title_full Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
title_fullStr Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
title_full_unstemmed Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
title_sort Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
dc.creator.none.fl_str_mv Arana-Calderón, César Alejandro
Chávez-Guevara, Sandra Paola
author Arana-Calderón, César Alejandro
author_facet Arana-Calderón, César Alejandro
Chávez-Guevara, Sandra Paola
author_role author
author2 Chávez-Guevara, Sandra Paola
author2_role author
dc.subject.none.fl_str_mv SARS-CoV-2
COVID-19
Risk Factors
Coronavirus Infections
Hospitalization
Mortality
Survival
Peru
topic SARS-CoV-2
COVID-19
Risk Factors
Coronavirus Infections
Hospitalization
Mortality
Survival
Peru
description Objective: To identify demographic, clinical, laboratory and treatment characteristics associated with mortality in hospitalized patients with SARS-CoV-2 pneumonia in a Level I Hospital of Peruvian Social Security, at La Libertad Network. Materials and Method: Retrospective cohort study. Cox proportional hazards model was used, calculating crude and adjusted hazard ratios (HR), and the Kaplan-Meier estimator was used to evaluate the overall survival curve and for each factor. Results: Of the 158 patients, the diagnosis was confirmed in 79.11%. Nearly 70% (68.99%) were men, the global median age was 65 years (IQR: 52-77), and it was higher in deceased subjects 69 years old (IQR: 61-80 years). Little more than half of this population (53.80%) had comorbidities, such as high blood pressure (27.85%), obesity (22.78%), and diabetes mellitus (13.92%). The median duration of symptoms prior to admission was 9 days (IQR: 6-11 days). HRs were determined for oxygen saturation less than 80% on admission with 0.21 FIO2, leukocytosis with associated lymphopenia, oxygen requirement at 0.80 FIO2 on admission, and moderate-severe ARDS. Such values were 1.54, 1.98, 2.07 and 2.91, respectively. Conclusions: The development of moderate-severe ARDS on admission, leukocytosis associated with lymphopenia, less than 80% hypoxemia on admission at 0.21 FIO2, and high-flow oxygen requirement since admission with 0.80 FIO2, were the only risk factors for mortality.
publishDate 2022
dc.date.none.fl_str_mv 2022-08-13
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2336
10.35663/amp.2022.392.2336
url https://amp.cmp.org.pe/index.php/AMP/article/view/2336
identifier_str_mv 10.35663/amp.2022.392.2336
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2336/1460
dc.rights.none.fl_str_mv Copyright (c) 2022 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 39 No 2 (2022): April - June
ACTA MEDICA PERUANA; Vol. 39 Núm. 2 (2022): Abril - Junio
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075111830126592
score 13.940932
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).